Identification of Efflux Pump Mutations in Pseudomonas aeruginosa from Clinical Samples
暂无分享,去创建一个
Metab Alharbi | I. Khan | Sadiq Azam | M. Haq | Z. Liaqat | Sajjad Ahmad | Sonia Quddus
[1] A. Asgari,et al. Expression of RND efflux pumps mediated antibiotic resistance in Pseudomonas aeruginosa clinical strains. , 2021, Microbial pathogenesis.
[2] S. Farajnia,et al. Molecular epidemiology and carbapenem resistance of Pseudomonas aeruginosa isolated from patients with burns. , 2021, Journal of wound care.
[3] T. Z. Salehi,et al. Evaluation of MexAB-OprM efflux pump and determination of antimicrobial susceptibility in Pseudomonas aeruginosa human and veterinary isolates , 2021, BULGARIAN JOURNAL OF VETERINARY MEDICINE.
[4] A. Meliani. The multifactorial resistance of Pseudomonas aeruginosa , 2020, EXCLI journal.
[5] M. Abdel-Daim,et al. Efflux MexAB-Mediated Resistance in P. aeruginosa Isolated from Patients with Healthcare Associated Infections , 2020, Pathogens.
[6] N. Narayanan,et al. Mutational and Phylogenetic Analysis of nfxB Gene in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa Hyperexpressing MexCD-OprJ Efflux Pump , 2019, Advances in Microbiology.
[7] K. Ghazvini,et al. Characterization of efflux pump-mediated resistance against fluoroquinolones among clinical isolates of Pseudomonas aeruginosa in the northeast of Iran and its association with mortality of infected patients , 2019 .
[8] B. Glick,et al. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. , 2019, Biotechnology advances.
[9] M. Katouli,et al. Pseudomonas aeruginosa: A review of their Pathogenesis and Prevalence in Clinical Settings and the Environment , 2016 .
[10] P. Ruggerone,et al. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity , 2015, Proceedings of the National Academy of Sciences.
[11] N. Jabeen,et al. Multi-drug resistant pseudomonas aeruginosa: a threat of nosocomial infections in tertiary care hospitals. , 2015, JPMA. The Journal of the Pakistan Medical Association.
[12] R. Hancock,et al. Pseudomonas aeruginosa: all roads lead to resistance. , 2011, Trends in microbiology.
[13] S. Lory,et al. Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic Fibrosis , 2010, Journal of bacteriology.
[14] V. Tam,et al. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes , 2010, Expert review of pharmacoeconomics & outcomes research.
[15] E. Velázquez,et al. Historical evolution and current status of the taxonomy of genus Pseudomonas. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[16] A. E. El Solh,et al. Update on the treatment of Pseudomonas aeruginosa pneumonia. , 2009, The Journal of antimicrobial chemotherapy.
[17] Jean-Marie Meyer,et al. Pyoverdines: pigments, siderophores and potential taxonomic markers of fluorescent Pseudomonas species , 2000, Archives of Microbiology.
[18] N. Gotoh,et al. Characterization of MexE–MexF–OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa , 1997, Molecular microbiology.